Skip to main content

Table 4 HIV, syphilis and STI prevalence among HR-MSM and TGs in Tamil Nadu in Round 1 and Round 2

From: Increasing condom use and declining STI prevalence in high-risk MSM and TGs: evaluation of a large-scale prevention program in Tamil Nadu, India

 

Round 1

Round 2

Crude OR

Adjusted OR^

p-value

% N = 2032

% N = 2006

(95% CI)

(95% CI)

(Wald test)

HR-MSM

HIV-1 infection

9.7

10.9

1.2 (0.7-1.9)

1.1 (0.7-1.9)

0.57

Reactive RPR + positive TPHA

14.3

6.8

0.43 (0.3-0.7)

0.37 (0.2-0.6)

<0.01

Reactive RPR >1:8 + positive TPHA

3.63

3.43

0.94 (0.5-1.8)

1.15 (0.6-2.35)

0.68

Chlamydia infection

0.68

0.51

0.74 (0.3-2.1)

2.2 (.5-8.9)

0.29

Gonorrhoea infection

0.07

0.15

2.0 (0.2-18.3)

6.9 (0.3-159.5)

0.23

Chlamydia and/or gonorrhoea infection

0.76

0.56

0.75 (0.3-2.2)

2.3 (.6-9.4)

0.24

HIV prevalence (district-wise)

     

Chennai

4.8

10.9

2.5 (1.1-5.2)

2.6 (0.97-6.8)

0.06

Coimbatore

6.5

11.2

1.8 (0.94-3.5)

2.2 (0.97-5.0)

0.06

Madurai

22.3

14.4

0.59 (0.24-1.4)

0.57 (0.23-1.4)

0.23

Salem

5.5

4.8

0.87 (0.29-2.6)

0.56 (0.18-1.7)

0.31

Syphilis prevalence (district wise)

     

Chennai

12.9

9.9

0.74 (5.0-16.6)

0.62 (0.3-1.4)

0.24

Coimbatore

14.5

6.3

0.39 (0.2-0.7)

0.37 (0.2-0.8)

<0.01

Madurai

17.8

6.6

0.34 (0.1-1.2)

0.25 (0.1-0.9)

<0.05

Salem

12.2

1.9

0.14 (0.1-0.4)

0.08 (0.0-0.2)

<0.01

TGs

HIV-1 infection

12

9.8

0.79 (0.4-1.6)

1.3 (0.5-3.2)

0.57

Reactive RPR + positive TPHA

16.6

4.2

0.22(0.1-0.4)

0.30 (0.1-0.7)

0.01

Reactive RPR >1:8 + positive TPHA

0

0

-

-

-

Chlamydia infection

0

0

-

--

-

Gonorrhoea infection

0

0

-

-

-

  1. ^Multivariate models were controlled for the following variables for HR-MSM analysis: self-identity, age, literacy, occupation, residency, age at first sex; and the following variables for TG: self-identification as aqua or nirvana aravani, district, age, literacy, occupation, age at first sex, and residency.
  2. Legend: Table 4 provides estimates of HIV prevalence and STI prevalence among HR-MSM and TGs; estimates for HR-MSM provided are overall and district-wise for HIV and syphilis; adjusted odds ratios are provided for change in estimates between IBBA R 1 and R 2.